SAGERX.COM: Keyword Density Checker

Total words: 2757 | 2-word phrases: 717 | 3-word phrases: 811 | 4-word phrases: 847

PAGE INFO

Title	Try to keep the title under 60 characters (71 characters) Biopharmaceutical Company for Brain Health Medicine \| Sage Therapeutics
Description	Try to keep the meta description between 50 - 160 characters (336 characters) Sage Therapeutics is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	in phase 2	5	0.62%
2	sage therapeutics inc	5	0.62%
3	brain health disorder	5	0.62%
4	more about our	4	0.49%
5	learn more about	4	0.49%
6	brain health disorders	4	0.49%
7	for the treatment	3	0.37%
8	the treatment of	3	0.37%
9	2 in phase	3	0.37%
10	phase 2 in	3	0.37%
11	studies will be	2	0.25%
12	neuropsychiatry franchise pipeline	2	0.25%
13	clinical trials early	2	0.25%
14	trials early access	2	0.25%
15	in phase 3	2	0.25%
16	collaborations about us	2	0.25%
17	about us missionvalues	2	0.25%
18	our team partnering	2	0.25%
19	partnering corporate social	2	0.25%
20	sponsorshipsgrants patient support	2	0.25%
21	our privacy policy	2	0.25%
22	working at sage	2	0.25%
23	and their families	2	0.25%
24	franchise neurology franchise	2	0.25%
25	prescribing information for	2	0.25%
26	investorsmedia clinical trials	2	0.25%
27	clinical trials contact	2	0.25%
28	trials contact us	2	0.25%
29	now leaving sagerxcom	2	0.25%
30	logo you are	2	0.25%

#	Keyword	Frequency	Density
1	learn more about our	4	0.47%
2	2 in phase 2	3	0.35%
3	phase 2 in phase	3	0.35%
4	for the treatment of	3	0.35%
5	team partnering corporate social	2	0.24%
6	therapeutic focus a new	2	0.24%
7	investorsmedia clinical trials contact	2	0.24%
8	clinical trials contact us	2	0.24%
9	our team partnering corporate	2	0.24%
10	patients and their families	2	0.24%
11	clinical trials early access	2	0.24%
12	sage therapeutics logo you	2	0.24%
13	disorders gabanmda receptors programsresearch	2	0.24%
14	health disorders gabanmda receptors	2	0.24%
15	a new approach to	2	0.24%
16	focus a new approach	2	0.24%
17	therapeutics logo you are	2	0.24%
18	healthcare providers visit the	2	0.24%
19	our medicines therapeutic focus	2	0.24%
20	in phase 2 in	2	0.24%
21	providers visit the sage	2	0.24%
22	approval by a health	1	0.12%
23	sage is a place	1	0.12%
24	and their families sage	1	0.12%
25	their families sage is	1	0.12%
26	of these studies will	1	0.12%
27	families sage is a	1	0.12%
28	outcome of these studies	1	0.12%
29	is a place where	1	0.12%
30	better for patients and	1	0.12%
31	unconventional thinking to solve	1	0.12%
32	thinking to solve problems	1	0.12%
33	to solve problems with	1	0.12%
34	solve problems with new	1	0.12%
35	the outcome of these	1	0.12%
36	problems with new ideas	1	0.12%
37	for patients and their	1	0.12%
38	brain health disorders to	1	0.12%
39	disorders to make life	1	0.12%
40	authority learn more about	1	0.12%

#	URL	Whois	Check
1	https://documents.sage-biogen.com/us/zurzuvae/pi.pdf	Whois	sage-biogen.com
2	https://documents.sage-biogen.com/us/zurzuvae/medguide.pdf	Whois	sage-biogen.com
3	https://documents.sage-biogen.com/us/zurzuvae/pi.pdf	Whois	sage-biogen.com
4	https://www.facebook.com/ThisIsSage	Whois	facebook.com
5	https://twitter.com/SageBiotech	Whois	twitter.com